End-of-day quote
Taipei Exchange
18:00:00 2024-06-19 EDT
|
5-day change
|
1st Jan Change
|
9.14
TWD
|
+0.55%
|
|
+0.77%
|
-18.76%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,856
|
1,819
|
2,189
|
9,882
|
2,735
|
1,924
|
Enterprise Value (EV)
1 |
3,889
|
1,904
|
2,746
|
10,076
|
2,959
|
1,973
|
P/E ratio
|
-35
x
|
-6.62
x
|
-6.82
x
|
-20.1
x
|
-5.8
x
|
-43.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.07
x
|
2.08
x
|
3.79
x
|
18.1
x
|
8.07
x
|
5.13
x
|
EV / Revenue
|
2.09
x
|
2.17
x
|
4.76
x
|
18.4
x
|
8.73
x
|
5.26
x
|
EV / EBITDA
|
-58.9
x
|
-9.47
x
|
-26.2
x
|
-49.8
x
|
-8.06
x
|
-12.6
x
|
EV / FCF
|
13.2
x
|
8.18
x
|
-7.93
x
|
-98.1
x
|
-13.6
x
|
43
x
|
FCF Yield
|
7.55%
|
12.2%
|
-12.6%
|
-1.02%
|
-7.33%
|
2.32%
|
Price to Book
|
2.62
x
|
1.58
x
|
2.6
x
|
11.1
x
|
5.78
x
|
4.65
x
|
Nbr of stocks (in thousands)
|
145,498
|
145,303
|
145,961
|
170,961
|
172,031
|
171,031
|
Reference price
2 |
26.50
|
12.52
|
15.00
|
57.80
|
15.90
|
11.25
|
Announcement Date
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,863
|
876.6
|
577.4
|
546.8
|
339.1
|
375
|
EBITDA
1 |
-65.98
|
-201.1
|
-104.9
|
-202.4
|
-367.3
|
-156.8
|
EBIT
1 |
-93.82
|
-240.3
|
-173.1
|
-271.7
|
-470.3
|
-254.7
|
Operating Margin
|
-5.04%
|
-27.41%
|
-29.98%
|
-49.69%
|
-138.68%
|
-67.92%
|
Earnings before Tax (EBT)
1 |
-99.81
|
-265.2
|
-307.7
|
-441.8
|
-489.2
|
-61.17
|
Net income
1 |
-109.6
|
-274.1
|
-320.3
|
-439.4
|
-470.4
|
-44.68
|
Net margin
|
-5.88%
|
-31.27%
|
-55.47%
|
-80.35%
|
-138.71%
|
-11.91%
|
EPS
2 |
-0.7571
|
-1.890
|
-2.200
|
-2.872
|
-2.741
|
-0.2600
|
Free Cash Flow
1 |
293.5
|
232.7
|
-346.3
|
-102.7
|
-216.8
|
45.84
|
FCF margin
|
15.76%
|
26.54%
|
-59.98%
|
-18.78%
|
-63.94%
|
12.22%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
33.5
|
85.1
|
557
|
195
|
224
|
48.6
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.507
x
|
-0.4233
x
|
-5.31
x
|
-0.9627
x
|
-0.609
x
|
-0.3101
x
|
Free Cash Flow
1 |
294
|
233
|
-346
|
-103
|
-217
|
45.8
|
ROE (net income / shareholders' equity)
|
-6.96%
|
-20.9%
|
-32.1%
|
-50.7%
|
-69.3%
|
-12.9%
|
ROA (Net income/ Total Assets)
|
-1.91%
|
-6.09%
|
-5.2%
|
-9%
|
-17.9%
|
-13.8%
|
Assets
1 |
5,737
|
4,503
|
6,162
|
4,881
|
2,627
|
324.3
|
Book Value Per Share
2 |
10.10
|
7.920
|
5.770
|
5.210
|
2.750
|
2.420
|
Cash Flow per Share
2 |
3.850
|
4.250
|
0.6700
|
1.920
|
1.390
|
0.7300
|
Capex
1 |
100
|
131
|
269
|
202
|
105
|
15.4
|
Capex / Sales
|
5.39%
|
14.89%
|
46.63%
|
36.97%
|
31.06%
|
4.11%
|
Announcement Date
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.76% | 48.28M | | +22.96% | 69.65B | | -4.86% | 46.9B | | +30.86% | 27.98B | | +9.47% | 19.58B | | +14.46% | 17.08B | | -11.15% | 15.08B | | -27.44% | 14.52B | | -32.93% | 11.54B | | -35.08% | 11.02B |
Other Specialty Chemicals
|